Doris N. McKinstry

2.2k total citations · 1 hit paper
25 papers, 1.8k citations indexed

About

Doris N. McKinstry is a scholar working on Molecular Biology, Cardiology and Cardiovascular Medicine and Pharmacology. According to data from OpenAlex, Doris N. McKinstry has authored 25 papers receiving a total of 1.8k indexed citations (citations by other indexed papers that have themselves been cited), including 10 papers in Molecular Biology, 8 papers in Cardiology and Cardiovascular Medicine and 7 papers in Pharmacology. Recurrent topics in Doris N. McKinstry's work include Protein Hydrolysis and Bioactive Peptides (7 papers), Renin-Angiotensin System Studies (6 papers) and Vitamin K Research Studies (4 papers). Doris N. McKinstry is often cited by papers focused on Protein Hydrolysis and Bioactive Peptides (7 papers), Renin-Angiotensin System Studies (6 papers) and Vitamin K Research Studies (4 papers). Doris N. McKinstry collaborates with scholars based in United States, Malaysia and Switzerland. Doris N. McKinstry's co-authors include Bruce H. Migdalof, Robert A. Vukovich, David B. Case, John H. Laragh, Jean E. Sealey, Steven A. Atlas, Haralambos Gavras, David A Willard, Sampat M. Singhvi and Hans R. Brunner and has published in prestigious journals such as Nature, New England Journal of Medicine and The Lancet.

In The Last Decade

Doris N. McKinstry

25 papers receiving 1.5k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Antihypertensive Effect of the Oral Angiotensin Converting-Enzyme Inhibitor SQ 14225 in Man

1978 516 citations Haralambos Gavras, Hans R. Brunner et al. New England Journal of Medicine profile →

Peers

Doris N. McKinstry

CCM

MB

ND

EDM

PHARM

Robert A. Vukovich United States

Charles S. Sweet United States

Keiji Kubo Japan

G. G. Belz Germany

Atsushi Numabe Japan

Joël de Leiris France

Brunner Hr Switzerland

Jean‐Pierre Desager Belgium

Anna Davoli Italy

Bruce H. Migdalof United States

Robert A. Vukovich United States

Doris N. McKinstry

623 ×0.7

CCM

549 ×0.6

MB

276 ×0.7

ND

192 ×0.7

EDM

97 ×0.5

PHARM

Citations per year, relative to Doris N. McKinstry Doris N. McKinstry (= 1×) peers Robert A. Vukovich

Countries citing papers authored by Doris N. McKinstry

Since Specialization

Citations

This map shows the geographic impact of Doris N. McKinstry's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Doris N. McKinstry with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Doris N. McKinstry more than expected).

Fields of papers citing papers by Doris N. McKinstry

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Doris N. McKinstry. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Doris N. McKinstry. The network helps show where Doris N. McKinstry may publish in the future.

Co-authorship network of co-authors of Doris N. McKinstry

This figure shows the co-authorship network connecting the top 25 collaborators of Doris N. McKinstry. A scholar is included among the top collaborators of Doris N. McKinstry based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Doris N. McKinstry. Doris N. McKinstry is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

1.

Duchin, Kenneth L., Doris N. McKinstry, Allen I. Cohen, & Bruce H. Migdalof. (1988). Pharmacokinetics of Captopril in Healthy Subjects and in Patients with Cardiovascular Diseases. Clinical Pharmacokinetics. 14(4). 241–259. 125 indexed citations

2.

Creasey, William A., Phillip T. Funke, Doris N. McKinstry, & A. Arthur Sugerman. (1986). Pharmacokinetics of Captopril in Elderly Healthy Male Volunteers. The Journal of Clinical Pharmacology. 26(4). 264–268. 20 indexed citations

3.

Duchin, Kenneth L., Michelle Stern, David A Willard, & Doris N. McKinstry. (1984). Comparison of kinetic interactions of nadolol and propranolol with cimetidine. American Heart Journal. 108(4). 1084–1086. 10 indexed citations

4.

Ivashkiv, Eugene, et al.. (1984). Identification and Determination of the S-Methyl Metabolite of Captopril in Human Plasma by Selected-Ion Monitoring Gas Chromatography-Mass Spectrometry. Journal of Pharmaceutical Sciences. 73(10). 1493–1495. 11 indexed citations

5.

Ivashkiv, Eugene, et al.. (1984). Determination of Total Captopril in Human Plasma by Gas Chromatography-Mass Spectrometry with Selected-Ion Monitoring After Reduction of Disulfides. Journal of Pharmaceutical Sciences. 73(8). 1113–1117. 26 indexed citations

6.

Swabb, Edward A., A. Arthur Sugerman, & Doris N. McKinstry. (1983). Multiple-dose pharmacokinetics of the monobactam azthreonam (SQ 26,776) in healthy subjects. Antimicrobial Agents and Chemotherapy. 23(1). 125–132. 33 indexed citations

7.

Singhvi, Sampat M., Doris N. McKinstry, James M. Shaw, David A Willard, & Bruce H. Migdalof. (1982). Effect of Food on the Bioavailability of Captopril in Healthy Subjects. The Journal of Clinical Pharmacology. 22(2-3). 135–140. 56 indexed citations

8.

Duchin, Kenneth L., Sampat M. Singhvi, David A Willard, Bruce H. Migdalof, & Doris N. McKinstry. (1982). Captopril kinetics. Clinical Pharmacology & Therapeutics. 31(4). 452–458. 102 indexed citations

9.

Singhvi, Sampat M., Kenneth L. Duchin, David A Willard, Doris N. McKinstry, & Bruce H. Migdalof. (1982). Renal handling of captopril: Effect of probenecid. Clinical Pharmacology & Therapeutics. 32(2). 182–189. 62 indexed citations

10.

Kripalani, K. J., Doris N. McKinstry, Sampat M. Singhvi, et al.. (1980). Disposition of captopril in normal subjects. Clinical Pharmacology & Therapeutics. 27(5). 636–641. 142 indexed citations

11.

Atlas, Steven A., David B. Case, Jean E. Sealey, John H. Laragh, & Doris N. McKinstry. (1979). Interruption of the renin-angiotensin system in hypertensive patients by captopril induces sustained reduction in aldosterone secretion, potassium retention and natruiresis.. Hypertension. 1(3). 274–280. 150 indexed citations

12.

Gavras, Haralambos, Hans R. Brunner, G. A. Turini, et al.. (1978). Antihypertensive Effect of the Oral Angiotensin Converting-Enzyme Inhibitor SQ 14225 in Man. New England Journal of Medicine. 298(18). 991–995. 516 indexed citations breakdown →

13.

Brunner, Hans-R., et al.. (1978). INNAPPROPRIATE RENIN SECRETION UNMASKED BY CAPTOPRIL (SQ 14 225) IN HYPERTENSION OF CHRONIC RENAL FAILURE. The Lancet. 312(8092). 704–707. 64 indexed citations

14.

Carson, John R., et al.. (1971). 5-Benzoyl-1-methylpyrrole-2-acetic acids as antiinflammatory agents. Journal of Medicinal Chemistry. 14(7). 646–647. 31 indexed citations

15.

McKinstry, Doris N. & George B. Koelle. (1967). EFFECTS OF DRUGS ON ACETYLCHOLINE RELEASE FROM THE CAT SUPERIOR CERVICAL GANGLION BY CARBACHOL AND BY PREGANGLIONIC STIMULATION. Journal of Pharmacology and Experimental Therapeutics. 157(2). 328–336. 26 indexed citations

16.

McKinstry, Doris N. & George B. Koelle. (1967). ACETYLCHOLINE RELEASE FROM THE CAT SUPERIOR CERVICAL GANGLION BY CARBACHOL. Journal of Pharmacology and Experimental Therapeutics. 157(2). 319–327. 32 indexed citations

17.

McKinstry, Doris N. & George B. Koelle. (1967). Inhibition of Release of Acetylcholine by Strychnine and its Implications regarding Transmission by the Olivo-cochlear Bundle. Nature. 213(5075). 505–506. 19 indexed citations

18.

Baer, John E., et al.. (1964). A New Class of Diuretic-Saluretic Agents, The , -Unsaturated Ketone Derivatives of Aryloxyacetic Acids. Experimental Biology and Medicine. 115(1). 87–90. 16 indexed citations

19.

McKinstry, Doris N., Edward Koenig, W. A. Koelle, & George B. Koelle. (1963). THE RELEASE OF ACETYLCHOLINE FROM A SYMPATHETIC GANGLION BY CARBACHOL: RELATIONSHIP TO THE FUNCTIONAL SIGNIFICANCE OF THE LOCALIZATION OF ACETYLCHOLINESTERASE. Canadian Journal of Biochemistry and Physiology. 41(1). 2599–2609. 12 indexed citations

20.

McKinstry, Doris N., Edward Koenig, W. A. Koelle, & George B. Koelle. (1963). THE RELEASE OF ACETYLCHOLINE FROM A SYMPATHETIC GANGLION BY CARBACHOL: RELATIONSHIP TO THE FUNCTIONAL SIGNIFICANCE OF THE LOCALIZATION OF ACETYLCHOLINESTERASE. Canadian Journal of Biochemistry and Physiology. 41(12). 2599–2609. 16 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact